Home -> Law Blog Directory -> Personal Injury Law Blogs -> Philadelphia Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Philadelphia Personal Injury LawyerSerious Adverse Events Linked to Chantix
By Jamie Sheller
Over 1000 serious adverse events associated with Chantix were reported in the first quarter of 2008. Chantix is a smoking cessation drug marketed by Pfizer. According to a drug safety watchdog group, due to the adverse event figures, Chantix is at the top of a list of drugs linked to serious injuries for that particular time period. The 1001 serious adverse events for the first quarter of 2008 include 50 deaths. The Institute for Safe Medication Practices gathered its information from the FDA's adverse event reporting system, but notes that the actual number of injuries may be higher due to the voluntary nature of the FDA's post-market surveillance system. The FDA has warned of suicide ideation among Chantix users. Since the FDA approved Chantix in 2006, there have been 3325 serious injuries reported, which include 112 deaths in the U.S.
Originally posted at InjuryBoard by Jamie Sheller
Full post as published by Philadelphia Personal Injury Lawyer on November 16, 2008 (boomark / email).
Medical Tubing Errors Leading to Adverse Events Including Death
Medical Tubing Errors Leading to Adverse Events Including Death
CellCept
Roche Issues Changes to Warnings and Adverse Events
Chantix Suicide
alleging the smoking cessation product is linked to increased suicidal behaviors.
NCAA and Ticketmaster
alleging they have a monopoly on college sports events and charge non-refundable fees to enter a lottery for the rights to purchase tickets to the sporting events.
Wrinkle-Fillers
FDA to Review Labeling due to Adverse Event Reports
Abacavir
Potential Increase Risk for Cardiac Events

FDA decides to perform second safety review of Pfizers Chantix
FDA: Chantix Anti-smoking Drug Needs A Warning
Pfizer Finds a Loophole in Advertising Chantix
Chantix: Vast Majority of Trial Participants Failed to Stay Smoke-Free
FDA warns Chantix may pose psychiatric risks
Chantix News Means Trouble for Pfizer








